Vertex Pharmaceuticals (VRTX) Fair Value & DCF

VRTX$547.03-0.86 -0.16%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$138.69BEnterprise value$140.66BRevenue (TTM)$12.99BMarket positionTop 25%

Score

47
Neutral
Value
16
Quality
85
Growth
41

Vertex Pharmaceuticals Incorporated (VRTX) trades at $547.03 on $138.69B of equity value, with a trailing P/E of 34.94. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Vertex Pharmaceuticals (VRTX) Fair Value & DCF

VRTX price $547.03 -0.86 -0.16%

Ticker
VRTX
Price
$547.03
Change
-0.86 -0.16%
Market cap
$138.69B
P/E
34.94
Forward P/E
29.13
Dividend yield
0.00%
Beta
0.32
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
47
Value
16
Quality
85
Growth
41

Stocklytics score rationale: value 16, quality 85, growth 41.

AI Score 85. Vertex Pharmaceuticals has a strong market capitalization of $134.5 billion and impressive profit margins, including a net profit margin of 30.6%. The company also maintains a robust clinical pipeline and has shown consistent revenue growth, with quarterly revenues reaching $3.44 billion recently, indicating solid fundamentals and growth potential

Insights · Forecast · Financials · Learn

Stocklytics home · Screener